Eggleston Karen, Ling Li, Qingyue Meng, Lindelow Magnus, Wagstaff Adam
UCLA International Institute, Los Angeles, CA, USA.
Health Econ. 2008 Feb;17(2):149-65. doi: 10.1002/hec.1306.
We report the results of a review of the Chinese- and English-language literatures on service delivery in China, asking how well China's health-care providers perform and what determines their performance. Although data and methodological limitations suggest caution in drawing conclusions, a critical reading of the available evidence suggests that current health service delivery in China leaves room for improvement, in terms of quality, responsiveness to patients, efficiency, cost escalation, and equity. The literature suggests that these problems will not be solved by simply shifting ownership to the private sector or by simply encouraging providers -- public and private -- to compete with one another for individual patients. By contrast, substantial improvements could be (and in some places have already been) made by changing the way providers are paid -- shifting away from fee-for-service and the distorted price schedule. Other elements of 'active purchasing' by insurers could further improve outcomes. Rigorous evaluations, based on richer micro-level data, could considerably strengthen the evidence base for service delivery policy in China.
我们报告了一项对中国医疗服务中英文文献的综述结果,探讨中国医疗服务提供者的表现如何以及哪些因素决定了他们的表现。尽管数据和方法上的局限性表明在得出结论时需谨慎,但对现有证据的批判性审视表明,中国当前的医疗服务在质量、对患者的响应性、效率、成本上升以及公平性方面仍有改进空间。文献表明,仅仅将所有权转移到私营部门,或者仅仅鼓励公立和私立医疗服务提供者相互竞争以争夺个体患者,并不能解决这些问题。相比之下,通过改变医疗服务提供者的支付方式——从按服务收费和扭曲的价格体系中转变出来,有望(并且在一些地方已经)取得实质性改善。保险公司的“积极购买”的其他要素也可以进一步改善结果。基于更丰富的微观层面数据进行的严格评估,可以大大加强中国医疗服务政策的证据基础。